Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
Open Access
- 27 September 2013
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 440
Abstract
The t(6;9)(p23;q34) chromosomal translocation is found in 1% of acute myeloid leukemia and encodes the fusion protein DEK-NUP214 (formerly DEK-CAN) with largely uncharacterized functions.Keywords
This publication has 37 references indexed in Scilit:
- mTOR complex 2 signaling and functionsCell Cycle, 2011
- The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformationLeukemia, 2010
- Dissecting the role of mTOR: Lessons from mTOR inhibitorsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Identification of a novel and myeloid specific role of the leukemia‐associated fusion protein DEK‐NUP214 leading to increased protein synthesisGenes, Chromosomes and Cancer, 2008
- Acute myeloid leukemia: Epidemiology and etiologyCancer, 2006
- A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignanciesLeukemia, 2006
- Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expressionBlood, 2004
- Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood, 2002
- Overexpression of the Nucleoporin CAN/NUP214 Induces Growth Arrest, Nucleocytoplasmic Transport Defects, and ApoptosisMolecular and Cellular Biology, 1998
- The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.Molecular and Cellular Biology, 1992